Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. 29 Sep Continue reading →
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. 28 May Continue reading →
Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. 22 Nov Continue reading →
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. 22 Nov Continue reading →
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis 22 Nov Continue reading →